John Armitage Eli Lilly & CO Transaction History
Egerton Capital (Uk) LLP
- $7.2 Billion
- Q1 2025
A detailed history of John Armitage (Egerton Capital (Uk) LLP) transactions in Eli Lilly & CO stock. As of the latest transaction made, Egerton Capital (Uk) LLP holds 492,808 shares of LLY stock, worth $370 Million. This represents 5.65% of its overall portfolio holdings.
Number of Shares
492,808
Previous 280,981
75.39%
Holding current value
$370 Million
Previous $217 Million
87.64%
% of portfolio
5.65%
Previous 3.25%
Shares
2 transactions
Others Institutions Holding LLY
# of Institutions
4,390Shares Held
821MCall Options Held
10MPut Options Held
10.8M-
Pnc Financial Services Group, Inc. Pittsburgh, PA101MShares$76.1 Billion44.13% of portfolio
-
Lilly Endowment Inc Indianapolis, IN96MShares$72.1 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA79.2MShares$59.5 Billion1.22% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$49.4 Billion1.37% of portfolio
-
State Street Corp Boston, MA34.4MShares$25.9 Billion1.2% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $713B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...